QNTM
NASDAQ · Pharmaceuticals
Quantum Biopharma-B Sub Vot
$2.11
-0.01 (-0.24%)
Open$2.05
Previous Close$2.11
Day High$2.17
Day Low$2.04
52W High$23.10
52W Low$2.85
Volume—
Avg Volume8.0K
Market Cap27.74M
P/E Ratio—
EPS$-5.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+350.4% upside
Current
$2.11
$2.11
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 23.70M | 7.61M | 6.92M |
| Net Income | -104,983,414 | 1.84M | 1.19M |
| Profit Margin | -19,353.5% | 24.2% | 17.2% |
| EBITDA | -64,989,293 | 2.64M | 2.30M |
| Free Cash Flow | — | 1.03M | 1.07M |
| Rev Growth | — | +16.6% | +5.5% |
| Debt/Equity | 0.02 | 0.64 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |